Variation of the Myelin Oligodendrocyte Glycoprotein gene is not primarily associated with multiple sclerosis in the Sardinian population
2007

Myelin Oligodendrocyte Glycoprotein Gene Variation and Multiple Sclerosis in Sardinia

Sample size: 397 publication Evidence: moderate

Author Information

Author(s): Marrosu Maria Giovanna, Murru Raffaele, Costa Gianna, Melis Maria Cristina, Rolesu Marcella, Schirru Lucia, Solla Elisabetta, Cuccu Stefania, Secci Maria Antonietta, Whalen Michael B, Cocco Eleonora, Pugliatti Maura, Sotgiu Stefano, Rosati Giulio, Cucca Francesco

Primary Institution: Centro Sclerosi Multipla, University of Cagliari, Italy

Hypothesis

Does variation in the MOG gene contribute independently to multiple sclerosis predisposition in the Sardinian population?

Conclusion

Variation within the MOG gene is not an important independent determinant of MS-inherited risk in the Sardinian population.

Supporting Evidence

  • 134 variants were detected in the MOG gene, with 33 being novel.
  • 11 SNPs showed evidence of association with MS at a significance level of 5%.
  • 8 markers showed significant association with MS in a total of 397 families analyzed.

Takeaway

The study looked at a gene related to multiple sclerosis in Sardinia and found that it doesn't really affect the risk of getting the disease.

Methodology

The MOG gene was resequenced in 21 healthy parents of MS patients, and variants were assessed for association with MS in 397 families using transmission disequilibrium tests.

Limitations

The study may not have detected rare variants that could influence disease risk due to sample size limitations.

Participant Demographics

The study included 397 independent MS families, primarily of Sardinian descent.

Statistical Information

P-Value

3.29 × 10-6

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2156-8-25

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication